TY - CHAP M1 - Book, Section TI - Guideline-Directed Medical Therapy for Patients with Stable Ischemic Heart Disease A1 - Newman, Jonathan D. A1 - Maron, David J. A2 - Samady, Habib A2 - Fearon, William F. A2 - Yeung, Alan C. A2 - King III, Spencer B. PY - 2017 T2 - Interventional Cardiology, 2e AB - Guideline-directed medical therapy (GDMT) is an intrinsic part of management of patients with stable ischemic heart disease (SIHD) whether or not revascularization is performed. GDMT for patients with coronary disease is synonymous with secondary prevention and consists of pharmacologic and lifestyle interventions. This chapter synthesizes the evidence base behind guideline-recommended therapies for secondary prevention. Outside of the use of aspirin, we will not discuss strategies of antiplatelet therapy for post-percutaneous coronary intervention (PCI) patients, which are reviewed elsewhere. Additionally, management of anginal symptoms is outside the scope of this chapter, and angina management in patients with SIHD will be discussed only briefly in the context of other targets for secondary prevention and risk factor modification. We will begin by reviewing the GDMT targets for risk factor modification in the 2012 SIHD guidelines.1 Following this, we will review the other medical therapies that have been shown to prevent death and myocardial infarction (MI) among patients with SIHD. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accesscardiology.mhmedical.com/content.aspx?aid=1146606683 ER -